<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39347447</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2096-7071</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>37</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>China CDC weekly</Title><ISOAbbreviation>China CDC Wkly</ISOAbbreviation></Journal><ArticleTitle>Development and Diagnosis Performance of IgM-Based Rapid Antigen Test for Early Detection of SARS-CoV-2 Infection in a Large Cohort of Suspected COVID-19 Cases - USA, Poland, and Sweden, 2021-2022.</ArticleTitle><Pagination><StartPage>953</StartPage><EndPage>961</EndPage><MedlinePgn>953-961</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.46234/ccdcw2024.199</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Antigen testing has been crucial in effectively managing the coronavirus disease 2019 (COVID-19) pandemic. This study evaluated the clinical performance of a nasopharyngeal swab (NPS)-based antigen rapid diagnostic test (Ag-RDT) compared to the gold standard real-time reverse transcription-polymerase chain reaction (RT-PCR) for early detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We developed an IgM-based rapid antigen test for early detection of SARS-CoV-2 infection. Between July 2021 and January 2022, we analyzed 1,030 NPS samples from participants at three centers in different countries, using both antigen rapid diagnostic tests (Ag-RDT) and RT-PCR.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The Ag-RDT demonstrated minimal detection limits as low as 0.1 ng/mL for recombinant N antigen and 100 TCID50/mL for heat-inactivated SARS-CoV-2 virus. Specificity assessments involving four human coronaviruses and 13 other respiratory viruses showed no cross-reactivity. The Ag-RDT assay (ALLtest) exhibited high sensitivity (93.18%-100%) and specificity (99.67%-100%) across all centers. Factors such as cycle threshold (Ct) values and the timing of symptoms since onset were influential, with sensitivity increasing at lower Ct values (&lt;30) and within the first week of symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The ALLtest Ag-RDT demonstrated high reliability and significant potential for diagnosing suspected COVID-19 cases.</AbstractText><CopyrightInformation>Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yihua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Lishui Second People's Hospital Affiliated to Wenzhou Medical University, Lishui City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pu</LastName><ForeName>Yiyi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Biomarkers and In Vitro Diagnosis Translation of Zhejiang province, School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Youhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Basic Medicine and Forensics, Key Laboratory of Bio-tech Vaccine of Zhejiang Province, Engineering Research Center of Novel Vaccine of Zhejiang Province, Hangzhou Medical College, Hangzhou City, Zhejiang Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yahan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Basic Medicine and Forensics, Key Laboratory of Bio-tech Vaccine of Zhejiang Province, Engineering Research Center of Novel Vaccine of Zhejiang Province, Hangzhou Medical College, Hangzhou City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>School of Basic Medicine and Forensics, Key Laboratory of Bio-tech Vaccine of Zhejiang Province, Engineering Research Center of Novel Vaccine of Zhejiang Province, Hangzhou Medical College, Hangzhou City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Litchev</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Longyou</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Lishui Second People's Hospital Affiliated to Wenzhou Medical University, Lishui City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Haojie</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Basic Medicine and Forensics, Key Laboratory of Bio-tech Vaccine of Zhejiang Province, Engineering Research Center of Novel Vaccine of Zhejiang Province, Hangzhou Medical College, Hangzhou City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Yunru</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Lishui Second People's Hospital Affiliated to Wenzhou Medical University, Lishui City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Lishui Second People's Hospital Affiliated to Wenzhou Medical University, Lishui City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Xiaojun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Research and Development, Hangzhou AllTest Biotech Co., Ltd, Hangzhou City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jinshu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Research and Development, Hangzhou AllTest Biotech Co., Ltd, Hangzhou City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Xianqin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Research and Development, Hangzhou AllTest Biotech Co., Ltd, Hangzhou City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Shaohong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Basic Medicine and Forensics, Key Laboratory of Bio-tech Vaccine of Zhejiang Province, Engineering Research Center of Novel Vaccine of Zhejiang Province, Hangzhou Medical College, Hangzhou City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Research and Development, Hangzhou AllTest Biotech Co., Ltd, Hangzhou City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Basic Medicine and Forensics, Key Laboratory of Bio-tech Vaccine of Zhejiang Province, Engineering Research Center of Novel Vaccine of Zhejiang Province, Hangzhou Medical College, Hangzhou City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Qingming</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Key Laboratory of Biomarkers and In Vitro Diagnosis Translation of Zhejiang province, School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou City, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>China CDC Wkly</MedlineTA><NlmUniqueID>101767554</NlmUniqueID><ISSNLinking>2096-7071</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IgM</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">antigen</Keyword><Keyword MajorTopicYN="N">early rapid diagnostic test</Keyword><Keyword MajorTopicYN="N">lateral flow chromatographic immunoassay</Keyword><Keyword MajorTopicYN="N">nasopharyngeal swab</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>17</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>17</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>10</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39347447</ArticleId><ArticleId IdType="pmc">PMC11427342</ArticleId><ArticleId IdType="doi">10.46234/ccdcw2024.199</ArticleId><ArticleId IdType="pii">ccdcw-6-37-953</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shrestha LB, Foster C, Rawlinson W, Tedla N, Bull RA Evolution of the SARS-CoV-2 omicron variants BA. 1 to BA.5: implications for immune escape and transmission. Rev Med Virol. 2022;32(5):e2381. doi: 10.1002/rmv.2381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2381</ArticleId><ArticleId IdType="pmc">PMC9349777</ArticleId><ArticleId IdType="pubmed">35856385</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi S, Bouvier N, Wexler AS, Ristenpart WD The coronavirus pandemic and aerosols: does COVID-19 transmit via expiratory particles? Aerosol Sci Technol. 2020;54(6):635–8. doi: 10.1080/02786826.2020.1749229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02786826.2020.1749229</ArticleId><ArticleId IdType="pmc">PMC7157964</ArticleId><ArticleId IdType="pubmed">32308568</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med. 2020;173(4):262–7. doi: 10.7326/M20-1495.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-1495</ArticleId><ArticleId IdType="pmc">PMC7240870</ArticleId><ArticleId IdType="pubmed">32422057</ArticleId></ArticleIdList></Reference><Reference><Citation>Brummer LE, Katzenschlager S, Gaeddert M, Erdmann C, Schmitz S, Bota M, et al Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: a living systematic review and meta-analysis. PLoS Med. 2021;18(8):e1003735. doi: 10.1371/journal.pmed.1003735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003735</ArticleId><ArticleId IdType="pmc">PMC8389849</ArticleId><ArticleId IdType="pubmed">34383750</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalid MF, Selvam K, Jeffry AJN, Salmi MF, Najib MA, Norhayati MN, et al Performance of rapid antigen tests for COVID-19 diagnosis: a systematic review and meta-analysis. Diagnostics (Basel) 2022;12(1):110. doi: 10.3390/diagnostics12010110.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12010110</ArticleId><ArticleId IdType="pmc">PMC8774565</ArticleId><ArticleId IdType="pubmed">35054277</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q, Shao WX, Meng HY Performance and application evaluation of SARS-CoV-2 antigen assay. J Med Virol. 2022;94(8):3548–53. doi: 10.1002/jmv.27798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27798</ArticleId><ArticleId IdType="pmc">PMC9088371</ArticleId><ArticleId IdType="pubmed">35445404</ArticleId></ArticleIdList></Reference><Reference><Citation>Greub G, Caruana G, Schweitzer M, Imperiali M, Muigg V, Risch M, et al Multicenter technical validation of 30 rapid antigen tests for the detection of SARS-CoV-2 (VALIDATE) Microorganisms. 2021;9(12):2589. doi: 10.3390/microorganisms9122589.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9122589</ArticleId><ArticleId IdType="pmc">PMC8704317</ArticleId><ArticleId IdType="pubmed">34946190</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohmer N, Toptan T, Pallas C, Karaca O, Pfeiffer A, Westhaus S, et al The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro. J Clin Med. 2021;10(2):328. doi: 10.3390/jcm10020328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10020328</ArticleId><ArticleId IdType="pmc">PMC7830733</ArticleId><ArticleId IdType="pubmed">33477365</ArticleId></ArticleIdList></Reference><Reference><Citation>Navero-Castillejos J, Casals-Pascual C, Narváez S, Cuesta G, Hurtado JC, Fernandez M, et al Diagnostic performance of six rapid antigen tests for SARS-CoV-2. Microbiol Spectr. 2022;10(2):e02351–21. doi: 10.1128/spectrum.02351-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02351-21</ArticleId><ArticleId IdType="pmc">PMC9045193</ArticleId><ArticleId IdType="pubmed">35293799</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Qavi AJ, Hachim A, Kavian N, Cole AR, Moyle AB, et al Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain. iScience. 2021;24(6):102681. doi: 10.1016/j.isci.2021.102681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102681</ArticleId><ArticleId IdType="pmc">PMC8168301</ArticleId><ArticleId IdType="pubmed">34095780</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu YY, Weng YH, Wu YH, Gao F, Zheng XJ, Xiong XQ, et al Antibody response to SARS-CoV-2 in the first batch of COVID-19 patients in China by a self-developed rapid IgM-IgG test. Front Cell Infect Microbiol. 2022;12:915751. doi: 10.3389/fcimb.2022.915751.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.915751</ArticleId><ArticleId IdType="pmc">PMC9204641</ArticleId><ArticleId IdType="pubmed">35719335</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, et al Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020;8(8):CD013705. doi: 10.1002/14651858.CD013705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013705</ArticleId><ArticleId IdType="pmc">PMC8078202</ArticleId><ArticleId IdType="pubmed">32845525</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheiblauer H, Filomena A, Nitsche A, Puyskens A, Corman VM, Drosten C, et al Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill. 2021;26(44):2100441. doi: 10.2807/1560-7917.ES.2021.26.44.2100441.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.44.2100441</ArticleId><ArticleId IdType="pmc">PMC8569926</ArticleId><ArticleId IdType="pubmed">34738515</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuit E, Venekamp RP, Veldhuijzen IK, van den Bijllaardt W, Pas SD, Stohr JJJM, et al Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional study. BMC Med. 2022;20(1):406. doi: 10.1186/s12916-022-02603-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02603-x</ArticleId><ArticleId IdType="pmc">PMC9590385</ArticleId><ArticleId IdType="pubmed">36280827</ArticleId></ArticleIdList></Reference><Reference><Citation>Samsunder N, Lustig G, de Vos M, Ngcapu S, Giandhari J, Tshiabuila D, et al Performance of rapid antigen tests in identifying Omicron BA. 4 and BA.5 infections in South Africa. J Clin Virol. 2023;165:105498. doi: 10.1016/j.jcv.2023.105498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2023.105498</ArticleId><ArticleId IdType="pmc">PMC10236920</ArticleId><ArticleId IdType="pubmed">37329842</ArticleId></ArticleIdList></Reference><Reference><Citation>Tom MR, Mina MJ To interpret the SARS-CoV-2 test, consider the cycle threshold value. Clin Infect Dis. 2020;71(16):2252–4. doi: 10.1093/cid/ciaa619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa619</ArticleId><ArticleId IdType="pmc">PMC7314112</ArticleId><ArticleId IdType="pubmed">32435816</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullard J, Dust K, Funk D, Strong JE, Alexander D, Garnett L, et al Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin Infect Dis. 2020;71(10):2663–6. doi: 10.1093/cid/ciaa638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa638</ArticleId><ArticleId IdType="pmc">PMC7314198</ArticleId><ArticleId IdType="pubmed">32442256</ArticleId></ArticleIdList></Reference><Reference><Citation>Igloi Z, Velzing J, van Beek J, van de Vijver D, Aron G, Ensing R, et al Clinical evaluation of Roche SD biosensor rapid antigen test for SARS-CoV-2 in municipal health service testing site, the Netherlands. Emerg Infect Dis. 2021;27(5):1323–9. doi: 10.3201/eid2705.204688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2705.204688</ArticleId><ArticleId IdType="pmc">PMC8084500</ArticleId><ArticleId IdType="pubmed">33724916</ArticleId></ArticleIdList></Reference><Reference><Citation>Jääskeläinen AE, Ahava MJ, Jokela P, Szirovicza L, Pohjala S, Vapalahti O, et al Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection. J Clin Virol. 2021;137:104785. doi: 10.1016/j.jcv.2021.104785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2021.104785</ArticleId><ArticleId IdType="pmc">PMC7934791</ArticleId><ArticleId IdType="pubmed">33711694</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith RD, Johnson JK, Clay C, Girio-Herrera L, Stevens D, Abraham M, et al Clinical evaluation of Sofia rapid antigen assay for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among emergency department to hospital admissions. Infect Control Hosp Epidemiol. 2022;43(8):968–73. doi: 10.1017/ice.2021.281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2021.281</ArticleId><ArticleId IdType="pmc">PMC8376850</ArticleId><ArticleId IdType="pubmed">34162449</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>